Treating Amiodarone-Induced Thyrotoxicosis With Radioactive Iodine
Document Type
Review
Publication Date
1-1-2004
Description
Amiodarone use in the United States is increasing including a role in advanced cardiac life support protocols. There has been a significant increase in hypothyroidism, destructive thyroiditis (type II), and iodine-induced thyrotoxicosis (type I) with amiodarone. Preexisting thyroid disease and status of iodine intake can determine the nature of iodine-induced thyroid disease. Treating amiodarone-induced thyrotoxicosis (AIT) may include traditional antithyroid agents, glucocorticoids, and surgery. Usually, it is assumed the radioactive iodine uptake (RAIU) will be low, and this choice as a treatment modality is excluded at the initial visit. We report a satisfactory outcome in a patient with AIT using radioactive iodine. The role of radioactive iodine in treating AIT is reviewed
Citation Information
Iskandar, Said B.; Jordan, Richard M.; and Peiris, Alan N.. 2004. Treating Amiodarone-Induced Thyrotoxicosis With Radioactive Iodine. Tennessee medicine : journal of the Tennessee Medical Association. Vol.97(9). 408-410. https://pubmed.ncbi.nlm.nih.gov/15497570/ PMID: 15497570 ISSN: 1088-6222